Report a potential product defect

Personal Details

Are you a…

If permitted by local regulations, do you want to be informed about the outcome of the complaint investigation?

I consent to my data being processed for the purpose of responding to my inquiry and in accordance with the Roche Privacy Policy & Privacy Notice for Pharmacovigilance.

You consent, by ticking the box above, to the processing of your data for the purposes of responding to your inquiry and in accordance with the Roche Privacy Notice for Pharmacovigilance, medical information and product complaints. If you do not consent to the data processing, we will not be able to reply to your message and kindly ask you to use other channels to contact us.

F. Hoffmann-La Roche Ltd ("Roche") has legal obligations to record and/or report product complaints. Therefore, for such purposes your data will be processed in accordance with specific drug safety legislation, as further described in the Roche Privacy Notice for Pharmacovigilance, medical information and product complaints.

Roche will keep a record of the personal data that you provide for the purpose of responding to your inquiry, to follow up on such requests, to maintain the information in the Roche product complaint database for reference and to comply with our legal and regulatory recording and reporting obligations. The retention time of data is in accordance with respective laws and regulations.

By including personal data of another data subject in the form, you represent the lawfulness of processing of such personal data.

The Privacy Policy provides further detailed information about your rights and how Roche processes personal data.

Concerning Risdiplam (Evrysdi), Phesgo, Xofluza, Polivy, Roaccutane, Rozlytrek, Enspryng (Satralizumab), Ronapreve (Casirivimab + Imdevimab), GAVRETO (Pralsetinib), Lunsumio, Vabysmo

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

If a pregnancy occurs while using Herceptin/PERJETA/Kadcyla/Phesgo or within 7 months following the last dose of Herceptin/Kadcyla/Phesgo or within 6 months following the last dose of PERJETA, please immediately report pregnancy to the local Roche Adverse Event line at +32 (0)2 525 82 99. Additional information will be requested during a Herceptin/PERJETA//Phesgo/Kadcyla-exposed pregnancy and the first year of the infant's life. This will enable Roche to better understand the safety of Herceptin/PERJETA/Kadcyla/Phesgo and to provide appropriate information to health authorities, healthcare providers and patients.

Product Selection

Do you suspect a product falsification?*

Product Information

Product selected

Please select the procedure to which your concern relates:*

Please select your product type (dosage form).*

Is your product available for return?

Complaint Details

What exactly is wrong with your Roche product? Upload photos of the defect.

How is it different from "normal"? Please add a detailed description of the defect (e.g. appearance, damage, leakage).

Describe at what point was the defect or issue discovered (e.g. when opening the box, before the administration, after the administration, at which handling step according to instructions of use or patient information leaflet)

Complaint Details Continued

How was the product stored?*

How long have you/patient/caregiver been using the product?*

Was the product administered at home or in a medical environment (e.g. doctors office)?*

By whom?

Did the administrator of the product receive any handling training?*

Has this complaint also been reported via an additional channel (e.g. Health Authority / Call center/ Pharmacy)?*

Have there been any side effects involved?*

Personal Details

Are you a…

If permitted by local regulations, do you want to be informed about the outcome of the complaint investigation?

Product Selection

Do you suspect a product falsification?*

Product Information

Product selected

Please select the procedure to which your concern relates:*

Please select your product type (dosage form).*

Is your product available for return?

Complaint Details

What exactly is wrong with your Roche product? Upload photos of the defect.

How is it different from "normal"? Please add a detailed description of the defect (e.g. appearance, damage, leakage).

Describe at what point was the defect or issue discovered (e.g. when opening the box, before the administration, after the administration, at which handling step according to instructions of use or patient information leaflet)

Complaint Details Continued

How was the product stored?*

How long have you/patient/caregiver been using the product?*

Was the product administered at home or in a medical environment (e.g. doctors office)?*

By whom?

Did the administrator of the product receive any handling training?*

Has this complaint also been reported via an additional channel (e.g. Health Authority / Call center/ Pharmacy)?*

Have there been any side effects involved?*

Personal Details

Are you a…

If permitted by local regulations, do you want to be informed about the outcome of the complaint investigation?

External Site